5000872025-04-012025-06-305000872025-06-305000872025-04-012025-06-30in-capmkt:OtherExpenses1Member5000872025-04-012025-06-30in-capmkt:ReportableSegments1Member5000872025-04-012025-06-30in-capmkt:ReportableSegments2Member5000872025-04-012025-06-30in-capmkt:ReportableSegments1Member5000872025-04-012025-06-30in-capmkt:ReportableSegments2Member5000872025-04-012025-06-30in-capmkt:ReportableSegments1Member5000872025-06-30in-capmkt:ReportableSegments1Member5000872025-04-012025-06-30in-capmkt:ReportableSegments2Member5000872025-06-30in-capmkt:ReportableSegments2Member5000872025-04-012025-06-30in-capmkt:ReportableSegments1Member5000872025-06-30in-capmkt:ReportableSegments1Member5000872025-04-012025-06-30in-capmkt:ReportableSegments2Member5000872025-06-30in-capmkt:ReportableSegments2Member5000872025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15000872025-04-012025-06-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares500087CIPLANOTLISTEDINE059A01026CIPLA LIMITEDMain BoardEquity2025-04-012026-03-312025-07-252025-07-01INRCroresQuarterlyFirst quarterMulti segment2025-07-2509:30:002025-07-2513:15:00Not applicable2025-04-012025-06-30UnauditedConsolidated695747000002585600000721603000001469350000010250200000-32366000001312300000014050000025272000001696320000054461000000176993000000176993000005295500000-5167000004778800000012920500000000-4400000129161000008141000001373020000012976200000-6010000013788200000-580000001615500000216.0716.060016.0716.06Since the characters in the notes exceed the set limit, it is requested to refer to the detailed notes in PDF result as uploaded on the Stock Exchanges. <BR> Other Expenses16963200000Pharmaceuticals65794200000New ventures44370000007023120000065650000069574700000Pharmaceuticals17272200000New ventures5676000001783980000014050000017699300000Pharmaceuticals0New ventures0000Pharmaceuticals0New ventures0000Segment assets and liabilities <BR> As certain assets and liabilities are deployed interchangeably across segments, it is not practically possible to allocate those assets and liabilities to each segment. Hence, the details of assets and liabilities have not been disclosed in the above table. <BR> Items that will not be reclassified to profit or loss-85400000-85400000-21500000Items that will be reclassified to profit or loss860900000860900000-17100000814100000